Form 4: STERIS plc CFO Michael Tokich Reports Routine Share Dispositions for Tax Obligations

STERIS plc's Senior Vice President and CFO, Michael J. Tokich, reported the disposition of 727 ordinary shares to cover tax withholdings related to the vesting of restricted stock awards.

Summary

• Michael J. Tokich, Senior Vice President and CFO of STERIS plc (STE), filed a Form 4 detailing recent transactions.
• On June 2, 2025, Mr. Tokich disposed of a total of 727 ordinary shares at a price of $242.08 per share.
• These dispositions were 'F' code transactions, indicating shares withheld by the Issuer to satisfy tax obligations upon the vesting of restricted stock awards.
• Specifically, 386 shares were withheld from 1,293 restricted shares awarded on May 31, 2023, and vested on June 2, 2025.
• An additional 172 shares were withheld from 573 restricted shares awarded on June 2, 2021, and vested on June 2, 2025.
• Furthermore, 169 shares were withheld from 564 restricted shares awarded on June 2, 2022, and vested on June 2, 2025.
• Following these transactions, Mr. Tokich directly beneficially owns 42,009 ordinary shares.
• He also indirectly holds 3,592 ordinary share equivalents through the STERIS Corporation 401(k) Plan as of June 2, 2025.
• As of June 3, 2025, 5,424 of his ordinary shares remain restricted, with various vesting dates extending through June 4, 2027.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions related to executive compensation and tax obligations, which are neutral in sentiment. It does not indicate any significant positive or negative operational or financial developments.

Positives

• The transactions represent the vesting of previously awarded restricted stock, indicating the fulfillment of long-term incentive compensation for the CFO.
• The retention of a significant number of shares (42,009 direct and 3,592 indirect) by a key executive aligns management's interests with shareholders.

Negatives

• The disposition of shares, even for tax purposes, reduces the executive's direct ownership stake, though this is a standard practice for restricted stock vesting.

Future Outlook

The document outlines future vesting schedules for Mr. Tokich's remaining restricted shares, indicating continued long-term incentive alignment through June 2027.

Industry Context

This Form 4 filing is a routine disclosure of executive compensation-related transactions, common across all publicly traded companies. It reflects standard practices for managing restricted stock unit vesting and associated tax obligations.

Comparison to Industry Standards

• The practice of withholding shares to cover tax obligations upon restricted stock vesting is a standard industry practice for executive compensation, consistent with how similar awards are handled at companies like Medtronic (MDT) or Stryker (SYK) in the medical technology sector.
• The reported share price of $242.08 reflects STERIS plc's market valuation at the time of the transaction, which can be compared to the stock performance of peers in the healthcare and life sciences industry.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and share ownership, confirming that a key executive continues to hold a substantial stake in the company.
• Employees: Reflects standard practices for equity compensation, which can be a component of broader employee incentive programs.

Next Steps

• Future vesting of remaining restricted shares for Michael J. Tokich on June 4, 2025 (1,141 shares), October 1, 2025 (144 shares), June 1, 2026 (1,293 shares), June 2, 2026 (564 shares), June 4, 2026 (1,141 shares), and June 4, 2027 (1,141 shares).

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation, Beneficial Ownership, Michael J. Tokich, CFO